In medication-overuse headache, fMRI shows long-lasting dysfunction in midbrain areas

Headache

Volumn 52, Issue 10, 2012, Pages 1520-1534

  Ferraro, Stefania ^a   Grazzi, Licia ^a   Muffatti, Riccardo ^b   Nava, Simone ^a   Ghielmetti, Francesco ^a   Bertolino, Nicola ^a   Mandelli, Maria Luisa ^c   Visintin, Eleonora ^a   Bruzzone, Maria Grazia ^a   Nigri, Anna ^a   Epifani, Francesca ^a   Bussone, Gennaro ^a   Chiapparini, Luisa ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

addiction; decision making under risk; functional magnetic resonance imaging; medication overuse headache; mesocorticolimbic dopamine circuit

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INDUCED HEADACHE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NEUROPHYSIOLOGY; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TRANSFORMED MIGRAINE; VENTRAL TEGMENTUM; VENTROMEDIAL PREFRONTAL CORTEX;

ADDICTION; DECISION-MAKING UNDER RISK; FUNCTIONAL MAGNETIC RESONANCE IMAGING; MEDICATION-OVERUSE HEADACHE; MESOCORTICOLIMBIC DOPAMINE CIRCUIT;

ADULT; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; MAGNETIC RESONANCE IMAGING; MESENCEPHALON; MIDDLE AGED; TIME FACTORS;

EID: 84869236771     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2012.02276.x     Document Type: Article

References (65)

1. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004; 24 (Suppl. 1): 9-160.
2. Biondi DM,. Is migraine a neuropathic pain syndrome? Curr Pain Headache Rep. 2006; 10: 167-178.
3. Diener HC, Limmroth V,. Medication-overuse headache: A worldwide problem. Lancet Neurol. 2004; 3: 475-483.
4. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB,. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia. 2004; 24: 483-490.
5. Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G,. Rates and predictors for relapse in medication overuse headache: A 1-year prospective study. Neurology. 2003; 60: 1682-1683.
6. Saper JR, Hamel RL, Lake AE, 3rd. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia. 2005; 25: 545-546.
7. Radat F, Creac'h C, Guegan-Massardier E, et al. Behavioral dependence in patients with medication overuse headache: A cross-sectional study in consulting patients using the DSM-IV criteria. Headache. 2008; 48: 1026-1036.
8. Fuh JL, Wang SJ, Lu SR, Juang KD,. Does medication overuse headache represent a behavior of dependence? Pain. 2005; 119: 49-55.
9. Calabresi P, Cupini LM,. Medication-overuse headache: Similarities with drug addiction. Trends Pharmacol Sci. 2005; 26: 62-68.
10. Zwart JA, Dyb G, Hagen K, Svebak S, Stovner LJ, Holmen J,. Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology. 2004; 62: 1540-1544.
11. Radat F, Creac'h C, Swendsen JD, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005; 25: 519-522.
12. Lundqvist C, Aaseth K, Grande RB, Benth JS, Russell MB,. The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus study of chronic headache. Pain. 2010; 148: 487-491.
13. Sances G, Galli F, Anastasi S, et al. Medication-overuse headache and personality: A controlled study by means of the MMPI-2. Headache. 2010; 50: 198-209.
14. Di Lorenzo C, Sances G, Di Lorenzo G, et al. The Wolframin His611Arg polymorphism influences medication overuse headache. Neurosci Lett. 2007; 424: 179-184.
15. Di Lorenzo C, Di Lorenzo G, Sances G, et al. Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain. 2009; 10: 349-355.
16. Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006; 129: 543-550.
17. Bowers MS, Chen BT, Bonci A,. AMPA receptor synaptic plasticity induced by psychostimulants: The past, present, and therapeutic future. Neuron. 2010; 67: 11-24.
18. Wise RA,. Roles for nigrostriatal-not just mesocorticolimbic-dopamine in reward and addiction. Trends Neurosci. 2009; 32: 517-524.
19. Everitt BJ, Hutcheson DM, Ersche KD, Pelloux Y, Dalley JW, Robbins TW,. The orbital prefrontal cortex and drug addiction in laboratory animals and humans. Ann N Y Acad Sci. 2007; 1121: 576-597.
20. Luscher C, Malenka RC,. Drug-evoked synaptic plasticity in addiction: From molecular changes to circuit remodeling. Neuron. 2011; 69: 650-663.
21. Grant S, Contoreggi C, London ED,. Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia. 2000; 38: 1180-1187.
22. Bartzokis G, Lu PH, Beckson M, et al. Abstinence from cocaine reduces high-risk responses on a gambling task. Neuropsychopharmacology. 2000; 22: 102-103.
23. Mintzer J, Burns A,. Anticholinergic side-effects of drugs in elderly people. J R Soc Med. 2000; 93: 457-462.
24. Whitlow CT, Liguori A, Livengood LB, et al. Long-term heavy marijuana users make costly decisions on a gambling task. Drug Alcohol Depend. 2004; 76: 107-111.
25. Dom G, Sabbe B, Hulstijn W, van den Brink W,. Substance use disorders and the orbitofrontal cortex: Systematic review of behavioural decision-making and neuroimaging studies. Br J Psychiatry. 2005; 187: 209-220.
26. Asensio S, Romero MJ, Romero FJ, et al. Striatal dopamine D2 receptor availability predicts the thalamic and medial prefrontal responses to reward in cocaine abusers three years later. Synapse. 2010; 64: 397-402.
27. Paulus MP, Hozack NE, Zauscher BE, et al. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology. 2002; 26: 53-63.
28. Goldstein RZ, Alia-Klein N, Tomasi D, et al. Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction? Am J Psychiatry. 2007; 164: 43-51.
29. Bolla KI, Eldreth DA, London ED, et al. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage. 2003; 19: 1085-1094.
30. Ersche KD, Sahakian BJ,. The neuropsychology of amphetamine and opiate dependence: Implications for treatment. Neuropsychol Rev. 2007; 17: 317-336.
31. de Greck M, Supady A, Thiemann R, et al. Decreased neural activity in reward circuitry during personal reference in abstinent alcoholics-a fMRI study. Hum Brain Mapp. 2009; 30: 1691-1704.
32. Wrase J, Schlagenhauf F, Kienast T, et al. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage. 2007; 35: 787-794.
33. Zheng Y, Watakabe A, Takada M, et al. Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans. Prog Neuropsychopharmacol Biol Psychiatry. 2009; 33: 701-706.
34. Andrasik F, Grazzi L, Usai S, Buse DC, Bussone G,. Non-pharmacological approaches to treating chronic migraine with medication overuse. Neurol Sci. 2009; 30 (Suppl 1): 89-93.
35. Beck AT, Steer RA, Ball R, Ranieri W,. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess. 1996; 67: 588-597.
36. Oldfield RC,. The assessment and analysis of handedness: The Edinburgh Inventory. Neuropsychologia. 1971; 9: 97-113.
37. Tom SM, Fox CR, Trepel C, Poldrack RA,. The neural basis of loss aversion in decision-making under risk. Science. 2007; 315: 515-518.
38. Talairach J, Tournoux P,. Co-Planar Stereotaxic Atlas of the Human Brain. Thieme: New York; 1988.
39. Minati L, Grisoli M, Franceschetti S, et al. Neural signatures of economic parameters during decision-making: A functional MRI (FMRI), electroencephalography (EEG) and autonomic monitoring study. Brain Topogr. 2012; 25: 73-96.
40. Napadow V, Dhond R, Kennedy D, Hui KK, Makris N,. Automated brainstem co-registration (ABC) for MRI. Neuroimage. 2006; 32: 1113-1119.
41. Volkow ND, Wang GJ, Fowler JS, et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature. 1997; 386: 830-833.
42. Gu H, Salmeron BJ, Ross TJ, et al. Mesocorticolimbic circuits are impaired in chronic cocaine users as demonstrated by resting-state functional connectivity. Neuroimage. 2010; 53: 593-601.
43. Beck A, Schlagenhauf F, Wustenberg T, et al. Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biol Psychiatry. 2009; 66: 734-742.
44. Buhler M, Vollstadt-Klein S, Kobiella A, et al. Nicotine dependence is characterized by disordered reward processing in a network driving motivation. Biol Psychiatry. 2010; 67: 745-752.
45. Due DL, Huettel SA, Hall WG, Rubin DC,. Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: Evidence from functional magnetic resonance imaging. Am J Psychiatry. 2002; 159: 954-960.
46. von Deneen KM, Liu Y,. Obesity as an addiction: Why do the obese eat more? Maturitas. 2011; 68: 342.
47. Stoeckel LE, Weller RE, Cook EW, 3rd, Twieg DB, Knowlton RC, Cox JE,. Widespread reward-system activation in obese women in response to pictures of high-calorie foods. Neuroimage. 2008; 41: 636-647.
48. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C,. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci. 2005; 8: 147-148.
49. Figee M, Vink M, de Geus F, et al. Dysfunctional reward circuitry in obsessive-compulsive disorder. Biol Psychiatry. 2011; 69: 867.
50. Cupini LM, De Murtas M, Costa C, et al. Obsessive-compulsive disorder and migraine with medication-overuse headache. Headache. 2009; 49: 1005.
51. Volkow ND, Fowler JS, Wang GJ,. The addicted human brain viewed in the light of imaging studies: Brain circuits and treatment strategies. Neuropharmacology. 2004; 47 (Suppl. 1): 3-13.
52. Saal D, Dong Y, Bonci A, Malenka RC,. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron. 2003; 37: 577-582.
53. D'Ardenne K, McClure SM, Nystrom LE, Cohen JD,. BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science. 2008; 319: 1264-1267.
54. Carter RM, Macinnes JJ, Huettel SA, Adcock RA,. Activation in the VTA and nucleus accumbens increases in anticipation of both gains and losses. Front Behav Neurosci. 2009; 3: 21.
55. Volkow ND, Li TK,. Drug addiction: The neurobiology of behaviour gone awry. Nat Rev Neurosci. 2004; 5: 963-970.
56. Bowirrat A, Oscar-Berman M,. Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome. Am J Med Genet B Neuropsychiatr Genet. 2005; 132B: 29-37.
57. Chen AL, Chen TJ, Waite RL, et al. Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions. Med Hypotheses. 2009; 72: 14-22.
58. Jaaskelainen SK, Rinne JO, Forssell H, et al. Role of the dopaminergic system in chronic pain-a fluorodopa-PET study. Pain. 2001; 90: 257-260.
59. Duerden EG, Albanese MC,. Localization of pain-related brain activation: A meta-analysis of neuroimaging data. Hum Brain Mapp. 2011; Dec 1. doi: 10.1002/hbm.21416. [Epub ahead of print].
60. Tebartz van Elst L, Hesslinger B, Thiel T, et al. Frontolimbic brain abnormalities in patients with borderline personality disorder: A volumetric magnetic resonance imaging study. Biol Psychiatry. 2003; 54: 163-171.
61. Friston KJ, Holmes AP, Worsley KJ,. How many subjects constitute a study? Neuroimage. 1999; 10: 1-5.
62. Genovese CR, Lazar NA, Nichols T,. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage. 2002; 15: 870-878.
63. Brett M, Johnsrude IS, Owen AM,. The problem of functional localization in the human brain. Nat Rev Neurosci. 2002; 3: 243-249.
64. Davies P,. Medication overuse headache: A silent pandemic. Pain. 2012; 153: 7-8.
65. Evans AC, Marrett S, Neelin P, et al. Anatomical mapping of functional activation in stereotactic coordinate space. Neuroimage. 1992; 1: 43-53.